Last reviewed · How we verify
NCT06303609: Pelvic Pain
Effects of Non-ablative Radiofrequency on Female Genito-pelvic Pain Disorder
NA trial testing nonablative radiofrequency in Pelvic Pain in 56 participants. Currently enrolling.
20 June 2026
Quick facts
| Lead sponsor | Centro de Atenção ao Assoalho Pélvico |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 56 |
| Start date | 20 April 2024 |
| Primary completion | 20 June 2026 |
| Estimated completion | 20 July 2026 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- nonablative radiofrequency
- Vaginal dilator
- Sham nonablative radiofrequency
Conditions studied
- Pelvic Pain — all drugs for Pelvic Pain →
Sponsor
Centro de Atenção ao Assoalho Pélvico
Who can join
Adults 18 to 45, female only, with Pelvic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized clinical trial is to verify the response of genito-pelvic pain disorders in women associated with inability to penetrate to the treatment with non-ablative radiofrequency. The main question it aims to answer is: Does non-ablative radiofrequency have a positive effect on the symptoms of genito-pelvic pain disorders associated with inability to penetrate? Before starting the intervention and at one week, one-, three- and six months after the end of the study, participants will be evaluated with 03 questionnaires (Female Sexual Function Index, Sexual Quality of Life and Perceived Stress Scale-10) and will score the visual analogue scale the level of pain with the penetration (from 0 to 10); participants will then undergo digital evaluation of the pelvic floor muscles, using vaginal dilators and electromyographic evaluation. After being randomized, participants will be divided into the Experimental Group and the Sham Group, being submitted to • the use of non-ablative radiofrequency in the anal and urogenital triangles, • the positioning of the vaginal dilator at the end of each session • and participants will be instructed to use the vaginal dilator at home daily. The researchers will compare the groups in relation to the ability to penetrate with reduced vaginal pain, sexual function, quality of sexual life and the correlation between pelvic muscle activity and perceived stress.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06303609
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pelvic Pain
Currently open trials in the same condition.
- NCT07241637 — Effect of Tele-Yoga on Pain, Fatigue, and Quality of Life in Endometriosis · NA · recruiting
- NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
- NCT06921174 — Comparison of the Effectiveness of Classical Perineal Massage Therapy Versus the Use of an Intravaginal Device to Reduce · Phase 2 · recruiting
- NCT06549985 — Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain · NA · recruiting
- NCT06955221 — Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis · NA · recruiting
Other Centro de Atenção ao Assoalho Pélvico trials
Trials by the same sponsor.
- NCT05993793 — Use of Fototherapy in the Treatment of Fissure in Ano · NA · completed
- NCT04998578 — Comparison Of Aesthetic Techniques For Rejuvenation Of Genital Region: A Randomized Clinical Trial · NA · unknown
- NCT03833726 — Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer Treatment · NA · completed
- NCT03500107 — Use of Blue Light Emitting Diode in the Treatment of Women With Bacterial Vaginosis: a Clinical Trial · NA · unknown
- NCT03506594 — Radiofrequency Non-ablative in the Treatment of Genitourinary Syndrome of Menopause · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06303609 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centro de Atenção ao Assoalho Pélvico
- Last refreshed: 29 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06303609.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing